AG0302-COVID19

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAG0302-COVID19
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Lower Respiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnges IncOsaka University
China Registration ClassN/A

Develop Information

Active CompaniesAnges Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Lower Respiratory Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A